KRAS and non-small cell lung carcinoma: This extends the finding of prior studies that ascribed altered PI3K–AKT and SRC signalling to Lkb1 loss in Kras‐driven NSCLC 14, 15, but we relate this to an alteration in histotype spectra, particularly an increase in ASCs.